Given that metformin can activate NRF2, which in turn blocks the activation of the NF-κB pathway38, the possibility that metformin attenuated both neuro-inflammation and stroke severity in an AMPK-independent manner cannot be excluded. This evidence concerns the gene NFKB1 and stroke disorder.